ScholarIQanswers from OpenAlex
Systemic Sclerosis and Related Diseases
TopicLeading institutions, researchers & key papers
Systemic Sclerosis and Related Diseases is a topic indexed in ScholarIQ from OpenAlex.
What is known about Systemic Sclerosis and Related Diseases?
ScholarIQrecord summary
This cluster of papers focuses on the pathogenesis, clinical manifestations, and treatment of systemic sclerosis, with an emphasis on fibrosis, autoantibodies, pulmonary involvement, and the role of TGF-ß signaling. It also explores genetic markers, endothelial dysfunction, and various treatment approaches including immunosuppressive therapy for this complex autoimmune disease.
How many works does Systemic Sclerosis and Related Diseases have?
ScholarIQindexed works
Systemic Sclerosis and Related Diseases has 350 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Systemic Sclerosis and Related Diseases?
ScholarIQopenalex
The OpenAlex for Systemic Sclerosis and Related Diseases is on the source record.
What are the most-cited papers on Systemic Sclerosis and Related Diseases?
ScholarIQmost cited works
Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population
Maureen D. Mayes, James V. Lacey, Jennifer Beebe‐Dimmer, Brenda W. Gillespie, B.C. Cooper, Timothy Laing, David Schottenfeld
Mapping and predicting mortality from systemic sclerosis
Muriel Elhaï, Christophe Meune, Marouane Boubaya, Jérôme Avouac, É. Hachulla, Alexandra Balbir‐Gurman, Gabriela Riemekasten, Paolo Airò, Beatriz Joven, Serena Vettori, Franco Cozzi, Susanne Ullman, László Czirják, Mohammed Tikly, Ulf Müller‐Ladner, Paola Caramaschi, Oliver Distler, Florenzo Iannone, Lidia P Ananieva, Roger Hesselstrand, Radim Bečvář, Armando Gabrielli, Nemanja Damjanov, Maria João Salvador, Valeria Riccieri, Carina Mihai, Gabriella Szűcs, Ulrich A. Walker, Nicolas Hunzelmann, Duška Martinović, Vanessa Smith, Carolina de Souza Müller, Carlomaurizio Montecucco, Daniela Opriș-Belinski, Francesca Ingegnoli, Panayiotis G. Vlachoyiannopoulos, Bojana Stamenković, Edoardo Rosato, Stefan Heitmann, Jörg H. W. Distler, Thierry Zénone, Matthias Seidel, Alessandra Vacca, Ellen De Langhe, Srđan Novak, Maurizio Cutolo, Luc Mouthon, Jörg Henes, Carlo Chizzolini, Carlos Alberto von Mühlen, Kamal Solanki, Simona Rednic, Lisa K. Stamp, Branimir Anić, Vera Ortiz-Santamaría, Maria De Santis, Şule Yavuz, Walter Alberto Sifuentes Giraldo, Emmanuel Chatelus, Jiří Štork, Jacob M. van Laar, Esthela Loyo, Paloma García de la Peña Lefebvre, Kilian Eyerich, Vanesa Cosentino, Juan José Alegre Sancho, Otylia Kowal‐Bielecka, Grégoire Rey, Marco Matucci‐Cerinic, Yannick Allanore
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
Keith Sullivan, Ellen Goldmuntz, Lynette Keyes-Elstein, Peter A. McSweeney, Ashley Pinckney, Beverly Welch, Maureen D. Mayes, Richard A. Nash, Leslie J. Crofford, Barry Eggleston, Sharon Castina, Linda M. Griffith, Julia Goldstein, Dennis Wallace, Oana Craciunescu, Dinesh Khanna, Rodney J. Folz, Jonathan Goldin, E. William St. Clair, James R. Seibold, Kristine Phillips, Shin Mineishi, Robert W. Simms, Karen K. Ballen, Mark H. Wener, George E. Georges, Shelly Heimfeld, Chitra Hosing, Stephen J. Forman, Suzanne Kafaja, Richard M. Silver, Leroy Griffing, Jan Storek, Sharon LeClercq, Richard Brasington, Mary Ellen Csuka, Christopher Bredeson, Carolyn A. Keever-Taylor, Robyn T. Domsic, M. Bashar Kahaleh, Thomas A. Medsger, Daniel E. Furst
Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease
Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements, Michael D. Roth, Daniel E. Furst, Richard M. Silver, Jonathan Goldin, Edgar Arriola, Charlie Strange, Marcy B. Bolster, James R. Seibold, D. Riley, Vivien Hsu, John Varga, Dean E. Schraufnagel, Arthur C. Theodore, Robert W. Simms, Robert A. Wise, Fred Wigley, Barbara White, Virginia Steen, Charles A. Read, Maureen D. Mayes, Ed Parsley, Kamal K. Mubarak, M. Kari Connolly, Jeffrey A. Golden, Mitchell A. Olman, Barri J. Fessler, Naomi F. Rothfield, Mark L. Metersky, Dinesh Khanna, Ning Li, Gang Li
Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis
Lenny van Bon, Alsya J. Affandi, Jasper Broen, Romy Christmann, Renoud J. Marijnissen, Lukasz Stawski, Giuseppina Farina, Giuseppina Stifano, Allison L. Mathes, Marta Cossu, Michael York, Cindy Collins, Mark H. Wenink, Richard Huijbens, Roger Hesselstrand, Tore Saxne, Mike DiMarzio, Dirk M. Wuttge, Sandeep K. Agarwal, John D. Reveille, Shervin Assassi, Maureen D. Mayes, Yanhui Deng, Joost P.H. Drenth, Jacqueline de Graaf, Martin den Heijer, Cees G. M. Kallenberg, Marc Bijl, Arnoud Loof, Wim B. van den Berg, Leo A. B. Joosten, Vanessa Smith, Filip De Keyser, Rafaella Scorza, C. Lunardi, Piet L. C. M. van Riel, Madelon C Vonk, Waander L. van Heerde, Stephan Meller, Bernhard Homey, Lorenzo Beretta, Mark Roest, Maria Trojanowska, Robert Lafyatis, Timothy R. D. J. Radstake
Where is Systemic Sclerosis and Related Diseases research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Systemic Sclerosis and Related Diseases is open access?
ScholarIQopen access share
67%OPEN ACCESS